With the onset and continued presence of the COVID-19 pandemic, global healthcare is challenged with critical shortages of equipment, facilities and impediments to blood supply. Implementation of PBM practices can help in this endeavor by focusing on evidence-based bundles of care to optimize both medical and surgical patients, thus limiting or eliminating the need for blood transfusions.
This webinar series will help in this endeavor by bringing the latest PBM information to healthcare providers globally.
June 24, 2021, 4 p.m. Eastern
Pierre R Tibi, MD
Chief, Cardiac Services, Yavapai Regional Medical Center
Matthew Warner, MD
Assistant Professor of Anesthesiology, Mayo Clinic, Rochester, MN
Course credit available March 18, 2021 – March 17, 2022.
Susan Goobie, MD, FRCPC
Associate Professor of Anesthesiology, Harvard Medical School
Senior Associate in Perioperative Anesthesia, Boston Children’s Hospital, Boston, MA
Download Dr. Goobie’s slides.
David Faraoni, MD, PhD, FAHA
Associate Professor, Dept of Anesthesiology and Pain Medicine, University of Toronto
Staff Anesthesiologist, Division of Cardiac Anesthesia, The Hospital for Sick Children, Toronto, CA
Download Dr. Faraoni’s slides.
Course credit available May 6, 2021 – May 5, 2022.
Aryeh Shander, MD, FCCM, FCCP, FASA
Clinical Professor of Anesthesiology and Perioperative Medicine, Rutgers New Jersey Medical School
Clinical Professor of Anesthesiology, Medicine & Surgery, Mount Sinai School of Medicine, New York
Course credit available from May 27, 2021 – May 26, 2022.
Course Title: SABM 2021 CME Webinars: Patient Blood Management–Optimizing the Care of Surgical Patients
Course Director: Carolyn Burns, MD
Release Date: March 11, 2021
Expiration Date: June 30, 2022
Estimated Time to Complete: 1 hour per webinar, 4 hours total
Credits Available: 4.0 (1 credit hour per webinar)
This activity is supported by an independent educational grant from Baxter Healthcare.
SABM 2021 CME Webinars: Patient Blood Management–Optimizing the Care of Surgical Patients
Jointly provided by the Postgraduate Institute for Medicine and Society for the Advancement of Patient Blood Management.
Released: March 11, 2021
Available for credit until: June 30, 2022
The estimated time to complete this activity is 4.0 hours.
Contact Postgraduate Institute for Medicine at www.pimed.com.
This activity is intended for Physicians, Registered Nurses, Pharmacists, Nurse Practitioners, and Laboratory Technicians. delivering care to adolescents and adults in the area of Patient Blood Management.
After completing this activity, the participant should be better able to:
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Society for the Advancement of Patient Blood Management. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education*
The Postgraduate Institute for Medicine designates this live material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*One credit hour per live or enduring session.
Enduring Session Course Credit Schedule:
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Aryeh Shander, MD, FCCM, FCCP, FASA has the following disclosures:
SPEAKERS BUREAU: Merck; CONSULTANT/SPEAKER: Masimo Corporation, CSL Behring, Gauss Surgical, Vifor Pharma, Octapharmaand Pharmaniaga; GRANT/RESEARCH: CSL Behring, Masimo, HbO2 Therapeutics, LLC; and CONSULTANT: USDOD, USDOJ AND USDHHS
Matthew A. Warner, MD has the following disclosures:
Research Financial Support: KL2 Mentored Career Development Program (NCATS/NIH, Mayo Clinic)
Planners and Managers
The PIM planners and managers have nothing to disclose. SABM planners and managers have nothing to disclose.
There is no fee for this course.
During the period March 11, 2021 through June 30, 2022 participants must 1) read the learning objectives and disclosures; 2) study the educational activity; and 3) complete the evaluation form. Once you have received your certificate, please print it for your records.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Opening image courtesy of Anna Shvets from Pexels.com.